Compounding Facility - NY Richmond, Staten Island 10312

Compounding Facility entered the industry of Business Services (Unclassified) in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 561499, which describes it as a Business Services (Unclassified). For further clarification, the SIC classifies this business under the code 7389 and described it as a Business Services (Unclassified). The business provides service to the B2B market.

To acquire more information, please contact by calling (718) 227-9801 during business hours. You can also write to the business’ Single Location at 3845 Richmond Avenue, Staten Island, New York NY 10312. You can also visit the company’s website at delcodrugs.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Compounding Facility
Place of Business: 3845 Richmond Avenue, Staten Island, NY 10312
Contact Number: (718) 227-9801
Website: delcodrugs.com
Type of Service: Business Services (Unclassified)
SIC Number: 7389
NAICS Number: 561499
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Compounding Facility is a company operating from Richmond, New York providing professional Business Services (Unclassified) and relevant B2B variables. It was founded in 2010 and registered with the SIC code 7389 as Business Services (Unclassified), and with the NAICS code 561499 as Business Services (Unclassified).

With a current employee count of 1 to 4, Compounding Facility has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative at (718) 227-9801 for related queries, or to locate its Single Location using the coordinates 40.54408,-74.16502.

The Single Location can also be found at the street address 3845 Richmond Avenue in Staten Island, New York 10312 and can be engaged online through the company website at delcodrugs.com, the company Twitter , and Facebook page .